The pharmaceutical industry is witnessing a significant shift in glucose therapy with the introduction of GLP-1 transdermal devices. These revolutionary delivery systems offer a possibly easy alternative to injections for individuals living with type 2 diabetes. By avoiding the necessity for frequent injections, GLP-1 adhesives promise to enhanc… Read More